Ami HTX Recall Issued by Spectral Instruments Inc

Source: FDA · United States

Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.

Spectral Instruments Inc is recalling 35 Ami HTX devices due to a momentary absence of the On-Screen "X-Ray On" banner during run readiness check.

What this FDA recall tells you, and what most readers miss

This notice was issued by FDA on September 9, 2026 and geographically references United States. The FDA classifies this as a Class II recall, with the stated reason "Momentary absence of On-Screen "X-Ray On" banner during run readiness check.", distributed united states.. FDA recall classes run from I (reasonable probability of serious harm) to III (unlikely to cause harm), so the class number is the fastest way to gauge severity here. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.

A quick skim tells you whether this affects you directly; a closer read tells you more. Check the scope, the source, and how recent the record is, then weigh it against related notices rather than treating any single one as a trend.

Before acting, the primary agency source is available to check alongside this summary. Its related labels are recall, product-safety, fda, Devices.

What Happened

Spectral Instruments Inc is conducting an FDA-mandated recall of the Ami HTX device because of a momentary absence of the On-Screen "X-Ray On" banner during run readiness check.

Which Products Are Affected

The recall involves the Ami HTX device. A total of 35 units are affected, covering all serial numbers. The products were distributed in the United States.

What You Should Do

Consumers with affected devices should follow guidance from the recalling firm or the FDA regarding the ongoing Class II recall.

Why This Matters

This Class II recall addresses a device malfunction that could result in temporary or reversible adverse health consequences.

Source

FDA recall number Z-2940-2026. Recalling firm: Spectral Instruments Inc, Tucson, AZ.

Original source: FDA Official Notice ↗

All FDA Recalls →

Elsewhere in the country: similar length or severity timing 8

Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.

What People Ask

Common questions about this FDA recall.

What is this FDA recall about?
Spectral Instruments Inc is recalling 35 Ami HTX devices due to a momentary absence of the On-Screen "X-Ray On" banner during run readiness check.
Which agency issued this alert?
This alert was issued by FDA. The original notice is available at the source link at the bottom of this article.
How is this recall classified, and why does that matter?
The FDA classifies this as a Class II recall, citing "Momentary absence of On-Screen "X-Ray On" banner during run readiness check." as the reason. Class I is the most serious (reasonable probability of serious harm), Class II is a moderate or temporary health risk, and Class III is unlikely to cause harm.
What area is affected?
This alert affects United States. Check with FDA for the most current geographic scope.
Where can I find more FDA Recalls updates?
Browse the full FDA Recalls feed on Areazine at areazine.com/recalls/fda/ for the latest updates from FDA and other agencies.